Why do Funding and Legal Structure Matter in Decentralized Clinical Trials?
Both sites and sponsors must consider how DCT funding and legal structures can impact sites and the study itself.
James Riddle and Willie Muehlhausen Discuss Digital Technology and Virtual Data Collection in Clinical Research
In this episode, we discuss the growth of decentralized clinical trial technology and how IRBs evolved to account for technology advancements.
Improving Patient Centricity and Research Access
There is an increasing challenge to find eligible patients and build trial awareness, so how should the industry address them?
The Key to Increasing Diversity in Decentralized Trials
Rosamund Round VP of Parexel’s Patient Innovation Center and DCTs shares key strategies for increasing diversity in decentralized trials.
Op-ed: Missing Elements of the Discussion on Decentralized Trials
Dr. Paul Evans, CEO of Velocity Clinical Research weighs in on what's missing in the discussion of decentralized trials.
Introduction to Decentralized Clinical Trials
Decentralized clinical trials and the solutions and services that support them are still taking shape in the new research landscape. Learn what they are, how they impact your responsibilities and explore solutions to challenges implementing decentralized clinical trials.
Adapting, Adopting, and Succeeding in a Decentralized Landscape
Join a discussion on the exponential evolution of clinical trials, uncover trends observed across the industry, and hear how leading research organizations have adapted to a decentralized landscape.
Ethical Issues in the Design and Review of Decentralized Research
This white paper aims to provide a framework to understand ethical issues and steps to take in deploying a decentralized trial
Defining Decentralized Clinical Trials and Understanding Their Nuances
It’s important to understand decentralized clinical trials are not one-size fits-all and oftentimes a hybrid approach is necessary. Read our latest blog outlining what to consider when rolling out decentralized clinical trials across multiple jurisdictions where laws, technological uptake, and populations will vary.